General Information of the Compound
| Compound ID |
CP0856509
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(4-{1-[2-(methylsulfonyl)ethyl]-4-piperidinyl}-2-propylphenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C43H45F2N7O4S
|
||||||||||||||||||
| Molecular Weight |
793.941
|
||||||||||||||||||
| Canonical SMILES |
CCCc1cc(C2CCN(CCS(C)(=O)=O)CC2)ccc1Nc1nccc(-c2c(-c3ccc(OCC)c(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C43H45F2N7O4S/c1-4-9-30-26-29(28-18-22-51(23-19-28)24-25-57(3,54)55)13-15-35(30)47-43-46-20-17-36(48-43)41-39(49-38-12-6-7-21-52(38)41)31-14-16-37(56-5-2)32(27-31)42(53)50-40-33(44)10-8-11-34(40)45/h6-8,10-17,20-21,26-28H,4-5,9,18-19,22-25H2,1-3H3,(H,50,53)(H,46,47,48)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LFUSMISZNRKHLX-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor